Ftse Mib
32.665,21
-2,81%
DAX
18.002,02
-1,43%
S&P 500
5.431,60
-0,04%
NASDAQ
17.688,88
0,12%
Bitcoin
66.124,20
0,18%
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ MyMD Pharmaceuticals Inc (MYMD) MyMD Pharmaceuticals Inc (MYMD) Notizie

MyMD Pharmaceuticals Inc

MYMD
1,93
-0,25 (-11,47%)
15 Giu 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
31/5/202414:00EDGAR2Form D - Notice of Exempt Offering of Securities
23/5/202422:05EDGAR2Form 8-K - Current report
21/5/202415:10EDGAR2Form 8-K - Current report
21/5/202415:00BWMyMD Pharmaceuticals Secures Strategic Investments
15/5/202423:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/3/202422:30EDGAR2Form 8-K - Current report
05/3/202417:00EDGAR2Form 8-K - Current report
05/3/202415:15BWMyMD Pharmaceuticals Regains Compliance with Nasdaq Minimum..
14/2/202421:13EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/2/202417:27EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202422:57EDGAR2Form 8-K - Current report
13/2/202417:45BWMyMD Pharmaceuticals Announces Reverse Stock Split to..
06/12/202315:15EDGAR2Form 8-K - Current report
06/12/202315:15BWMyMD Pharmaceuticals Plans FDA-Cleared Phase 2 Clinical..
19/10/202315:00EDGAR2Form 8-K - Current report
19/10/202315:00BWMyMD Announces Preclinical Study Results Showing Novel..
13/10/202323:00EDGAR2Form 8-K - Current report
04/10/202322:30EDGAR2Form 8-K - Current report
04/10/202313:30BWMyMD Pharmaceuticals to Present Updated Statistically..
08/9/202323:24EDGAR2Form 8-K - Current report
24/8/202323:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/8/202322:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202323:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202314:30EDGAR2Form 8-K - Current report
14/8/202314:30BWFDA Accepts MyMD Pharmaceuticals’ Investigational New Drug..
03/8/202322:30EDGAR2Form 8-K - Current report
02/8/202314:30BWMyMD Pharmaceuticals to Hold Conference Call Today to..
01/8/202322:30EDGAR2Form 8-K - Current report
31/7/202315:00EDGAR2Form 8-K - Current report
31/7/202315:00BWMyMD Pharmaceuticals Reports Statistically Significant..
21/7/202322:30EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
14/7/202314:30EDGAR2Form 8-K - Current report
30/6/202322:30EDGAR2Form DEF 14A - Other definitive proxy statements
Apertura: 2,15 Min: 2,12 Max: 2,195
Chiusura: 2,18

La tua Cronologia

NASDAQ
MYMD
MyMD Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network